Texas Developmental Center for AIDS Research

德克萨斯艾滋病研究发展中心

基本信息

  • 批准号:
    10609473
  • 负责人:
  • 金额:
    $ 115.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-23 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY – TEXAS DEVELOPMENTAL CENTER FOR AIDS RESEARCH In 2019, the US announced a plan to End the HIV Epidemic by 2030. To be successful, strategies that improve HIV prevention and HIV treatment outcomes are needed. Only 56% of people with HIV (PWH) were virally suppressed in 2018, a critical determinant of health outcomes and transmission risk, and 51% of HIV diagnoses in 2018 were in the US South, despite constituting only 38% of the population in the US. Texas is the second most populous state in the US, behind California, with about 29 million residents, and is in the US South as defined by CDC and the Census Bureau. Unfortunately, this large Texas population, coupled with weaker public health and prevention policies and funding across the US South, has a growing HIV population that lags in critical health outcomes. There is an urgent need for more research and research infrastructure to combat the HIV epidemic in the US South and specifically in Texas to both contribute to ending the US HIV epidemic and to learn how to best do that in resource constrained areas of the US. We therefore will establish a Texas Developmental Center for AIDS Research (D-CFAR) to support the overall mission of the national CFAR program by facilitating high-priority HIV research and supporting the effort to end the HIV epidemic in the US. Three institutions have collaborated to propose this D-CFAR: Baylor College of Medicine in Houston, The University of Texas Health Science Center at Houston and the Texas Biomedical Research Institute in San Antonio. Based upon the outstanding expertise of its investigators, the Texas D-CFAR will focus its activities in the five-year funding period on the research theme “Ending HIV and Optimizing HIV Health in Texas.” To accomplish its goals, the Texas D-CFAR will: 1) Provide organizational and financial management and facilitate activities and programs that strengthen and enrich the D-CFAR research and intellectual environment; 2) Support targeted high-priority interdisciplinary pilot research projects, assist in responding to new HIV-related research initiatives, and facilitate research on ending HIV and improving health of PWH in Texas; and 3) Provide state-of-the-art expertise, advice, and services to facilitate the range of HIV-related research for D-CFAR investigators. The Texas D-CFAR will support an Administrative Core, a Developmental Core, a Basic Science Core and a Clinical and Biostatistics Core to meet investigator needs and catalyze innovative research. The scientific Cores will build on outstanding strengths in virology, non-human primate resources, clinical trials research and biostatistics. The D-CFAR will engage a Community Advisory Board and Internal and External Advisory Boards for guidance. Coupled with outstanding institutional support, the D- CFAR will stimulate new research and collaborations among basic, translational, clinical, health services and public health researchers. The D-CFAR will significantly advance knowledge needed to end HIV and improve the health of PWH in Texas and similar areas, train the next generation of scientists, and grow into a full CFAR, thereby contributing to ending the HIV epidemic in Texas, the US South, and beyond.
项目总结-德克萨斯州艾滋病研究发展中心

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas P Giordano其他文献

The New Era of Long-Acting Antiretroviral Therapy: When and Why to Make the Switch
长效抗逆转录病毒治疗的新时代:何时以及为何进行转变
  • DOI:
    10.1007/s11904-023-00665-x
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Melanie C Goebel;Emmanuel Guajardo;Thomas P Giordano;Shital M Patel
  • 通讯作者:
    Shital M Patel

Thomas P Giordano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas P Giordano', 18)}}的其他基金

Wastewater Sampling: A New Tool to Accelerate Ending the HIV Epidemic
废水采样:加速结束艾滋病毒流行的新工具
  • 批准号:
    10762555
  • 财政年份:
    2023
  • 资助金额:
    $ 115.65万
  • 项目类别:
Texas Developmental Center for AIDS Research
德克萨斯艾滋病研究发展中心
  • 批准号:
    10901388
  • 财政年份:
    2021
  • 资助金额:
    $ 115.65万
  • 项目类别:
Administrative Core A
行政核心A
  • 批准号:
    10609474
  • 财政年份:
    2021
  • 资助金额:
    $ 115.65万
  • 项目类别:
Texas Developmental Center for AIDS Research
德克萨斯艾滋病研究发展中心
  • 批准号:
    10397168
  • 财政年份:
    2021
  • 资助金额:
    $ 115.65万
  • 项目类别:
Administrative Core A
行政核心A
  • 批准号:
    10397169
  • 财政年份:
    2021
  • 资助金额:
    $ 115.65万
  • 项目类别:
Administrative Core A
行政核心A
  • 批准号:
    10901389
  • 财政年份:
    2021
  • 资助金额:
    $ 115.65万
  • 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
  • 批准号:
    10329924
  • 财政年份:
    2020
  • 资助金额:
    $ 115.65万
  • 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
  • 批准号:
    9721402
  • 财政年份:
    2020
  • 资助金额:
    $ 115.65万
  • 项目类别:
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
VA 视频连接可改善获得多学科专业护理的机会
  • 批准号:
    10561628
  • 财政年份:
    2020
  • 资助金额:
    $ 115.65万
  • 项目类别:
Developing an Intervention to Retain HIV-infected Veterans in HIV Care
制定干预措施,让感染艾滋病毒的退伍军人继续接受艾滋病毒护理
  • 批准号:
    8182121
  • 财政年份:
    2010
  • 资助金额:
    $ 115.65万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 115.65万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 115.65万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 115.65万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 115.65万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 115.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了